The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Cyclodextrins in drug delivery
Abstract
Cyclodextrins are a family of cyclic oligosaccharides with a hydrophilic outer surface and a lipophilic central cavity. Cyclodextrin molecules are relatively large with a number of hydrogen donors and acceptors and, thus, in general they do not permeate lipophilic membranes. In the pharmaceutical industry cyclodextrins have mainly been used as complexing agents to increase aqueous solubility of poorly soluble drugs, and to increase their bioavailability and stability. Studies in both humans and animals have shown that cyclodextrins can be used to improve drug delivery from almost any type of drug formulation. However, the addition of cyclodextrins to existing formulations without further optimisation will seldom result in acceptable outcome. Currently there are approximately 30 different pharmaceutical products worldwide containing drug/cyclodextrin complexes on the market.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 6×
“, poorly soluble/poorly permeable) drugs according to the Biopharmaceutics Classification System [4].”
BackgroundMethodInfluentialDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
Higuchi, T., & Connors, A. (1965) · Cited by 2,554
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Self-citationThe Stability of Cyclodextrin Complexes in Solution
Connors, K. A. (1997) · Chemical Reviews · doi:10.1021/cr960371r · Cited by 2,175
Cyclodextrin Drug Carrier Systems
Uekama, K., Hirayama, F., & Irie, T. (1998) · Chemical Reviews · doi:10.1021/cr970025p · Cited by 2,145
Evaluation of certain food additives and contaminants
Sharma, A. (2018) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_85_17 · Cited by 1,538
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Higuchi, T. (1965) · Cited by 1,143
Industrial Applications of Cyclodextrins
Hedges, A. R. (1998) · Chemical Reviews · doi:10.1021/cr970014w · Cited by 1,068
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
Frömming, K.-H., & Szejtli, J. (1994) · Topics in Inclusion Science · doi:10.1007/978-94-015-8277-3 · Cited by 658
A Practical Guide for the Determination of Binding Constants
Hirose, K. (2001) · Journal of inclusion phenomena and macrocyclic chemistry · doi:10.1023/a:1011117412693 · Cited by 605
Drug Delivery via the Mucous Membranes of the Oral Cavity
Harris, D., & Robinson, J. R. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810102 · Cited by 558
Cyclodextrins in topical drug formulations: theory and practice
Loftsson, T., & Masson, M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00761-x · Cited by 475
Self-citationMechanisms of drug release from cyclodextrin complexes
Stella, V. J., Rao, V. M., Zannou, E. A., & Zia, V. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00052-0 · Cited by 442
Self-Association of Cyclodextrins and Cyclodextrin Complexes
Loftsson, T., Másson, M., & Brewster, M. E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20047 · Cited by 426
Self-citationCyclodextrinsEnabling Excipients: Their Present and Future Use in Pharmaceuticals
Thompson, D. O. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i1.10 · Cited by 421
Organic Reactions Mediated by Cyclodextrins
Takahashi, K. (1998) · Chemical Reviews · doi:10.1021/cr9700235 · Cited by 408
New trends in cyclodextrins and derivatives
Duchêne, D. (1991) · Cited by 356
Design and Evaluation of Cyclodextrin-Based Drug Formulation
Uekama, K. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.900 · Cited by 356
French, D. (1957) · Advances in carbohydrate chemistry · doi:10.1016/s0096-5332(08)60209-x · Cited by 336
Effects of physicochemical properties and other factors on systemic nasal drug delivery
Behl, C. R., Pimplaskar, H. K., Sileno, A. P., deMeireles, J., & Romeo, V. D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00063-x · Cited by 312
Cyclodextrins in ophthalmic drug delivery
Loftssona, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00055-6 · Cited by 305
D’Souza, V. T., & Lipkowitz, K. B. (1998) · Chemical Reviews · doi:10.1021/cr980027p · Cited by 303
Role of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
Self-citationSelf‐Association and Cyclodextrin Solubilization of Drugs
Loftsson, T., Magnúsdóttir, A., Másson, M., & Sigurjónsdóttir, J. F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10226 · Cited by 277
Self-citationMinimizing systemic absorption of topically administered ophthalmic drugs
Urtti, A., & Salminen, L. (1993) · Survey of Ophthalmology · doi:10.1016/0039-6257(93)90141-s · Cited by 265
Cyclodextrins in nasal drug delivery
Merkus, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00054-4 · Cited by 221
Cyclodextrins in transdermal and rectal delivery
Matsuda, H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00056-8 · Cited by 196
Population Characteristics of Cyclodextrin Complex Stabilities in Aqueous Solution
Connors, K. A. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840712 · Cited by 188
Formulation and stability testing of photolabile drugs
Tønnesen, H. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00746-3 · Cited by 173
Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye
Loftsson, T., & Stefánsson, E. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800205.x · Cited by 173
Self-citationPrime, D. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00510-3 · Cited by 170
(2001) · Qualitätsförderung in Praxis und Klinik · doi:10.1055/b-0034-11034 · Cited by 159
Drug/Cyclodextrin/Hydroxy Acid Multicomponent Systems. Properties and Pharmaceutical Applications
Redenti, E., Szente, L., & Szejtli, J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<1::aid-jps1>3.0.co;2-w · Cited by 154
Marttin, E., Verhoef, J. C., & Merkus, F. W. H. M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997878 · Cited by 147
Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
Merkus, F. W. H. M., Verhoef, J. C., Romeijn, S. G., & Schipper, N. G. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015896405389 · Cited by 146
Cyclodextrins and the Biopharmaceutics Classification System of Drugs
Loftsson, Þ. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023088423667 · Cited by 145
Spontaneous Opalescence of Aqueous γ-Cyclodextrin Solutions: Complex Formation or Self-Aggregation?
Szente, L., Szejtli, J., & Kis, G. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9704341 · Cited by 126
Redenti, E., Szente, L., & Szejtli, J. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1050 · Cited by 123
Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray
Loftsson, T. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00580-9 · Cited by 116 · cited 1×
“Recently, promising results from nasal delivery of dihydroergotamine [92], midazolam [93], acyclovir [94] and heparins [95] have been reported.”
BackgroundKang, F., Jiang, G., Hinderliter, A. K., DeLuca, P. P., & Singh, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1015354028908 · Cited by 96
When can cyclodextrins be considered for solubilization purposes?
Rao, V. M., & Stella, V. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10341 · Cited by 93
Improvement of the Oral Bioavailability of Digitalis Glycosides by CyclodextrinComplexation
Uekama, K., FUJINAGA, T., Hirayama, F., Otagiri, M., Yamasaki, M., Seo, H., Hashimoto, T., & Tsuruoka, M. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721125 · Cited by 90
The BCS: Where Do We Go from Here?
Dressman, J., Butler, J., Hempenstall, J., & Reppas, C. I. (2001) · Pharmaceutical technology · Cited by 89
Savolainen, J., Järvinen, K., Taipale, H., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011900527021 · Cited by 88
Enhancing effects of cyclodextrins on nasal absorption of insulin in rats
Irie, T., Wakamatsu, K., Arima, H., Aritomi, H., & Uekama, K. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90053-5 · Cited by 84
Bentley, M. V. L. B., Lopez, R. F. V., Wilson, S., & Collett, J. H. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06813.x · Cited by 82
Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies
Yang, T., Hussain, A., Paulson, J. R., Abbruscato, T. J., & Ahsan, F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032998.84488.7a · Cited by 77
Matsubara, K., Abe, K., Irie, T., & Uekama, K. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841108 · Cited by 74
Nasal Absorption Enhancement of 17β-Estradiol by Dimethyl-β-Cyclodextrin in Rabbits and Rats
Hermens, W. A. J. J., Deurloo, M. J. M., Romeyn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (1990) · Pharmaceutical Research · doi:10.1023/a:1015816716544 · Cited by 73
Stabilisation of ionic drugs through complexation with non-ionic and ionic cyclodextrins
Másson, M., Loftsson, Þ., Jónsdóttir, S., Friđriksdóttir, H., & Petersen, D. S. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00387-6 · Cited by 66
Self-citationTopically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits
Loftsson, Þ., Friðriksdóttir, H., Stefánsson, E., Thórisdóttir, S., Gudmundsson, Ó. S., & Sigthórsson, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03835.x · Cited by 65
Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes
Veiga, F., Fernandes, C., & Teixeira, F. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00445-2 · Cited by 62
Schipper, N. G. M., Hermens, W. A. J. J., Romeyn, S. G., Verhoef, J., & Merkus, F. W. H. M. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90179-8 · Cited by 58
Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs.
Loftsson, Þ., Sigurðsson, H. H., Másson, M., & Schipper, N. G. M. (2004) · PubMed · Cited by 57
Self-citationFelton, L. A., Wiley, C. J., & Godwin, D. A. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120014578 · Cited by 57
Jarho, P., Urtti, A. O., Pate, D. W., Suhonen, P., & Järvinen, T. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04522-x · Cited by 55
Self-citationThe Solid‐State Stability of Amorphous Quinapril in the Presence of β‐Cyclodextrins
Li, J., Guo, Y., & Zografi, G. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10014 · Cited by 51
Nasal Absorption of Dihydroergotamine from Liquid and Powder Formulations in Rabbits
Marttin, E., Romeijn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960500j · Cited by 51
ChemInform Abstract: Methods of Investigating and Preparing Inclusion Compounds
Hirayama, F., & Uekama, K. (1990) · ChemInform · doi:10.1002/chin.199012376 · Cited by 51
Soliman, O. A.-E., Kimura, K., Hirayama, F., et al. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04862-4 · Cited by 48
Hydroxypropyl‐β‐cyclodextrin inhibits spray‐drying‐induced inactivation of β‐galactosidase
Branchu, S., Forbes, R. T., York, P., Petrén, S., Nyqvist, H., & Camber, O. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9804819 · Cited by 47
Acute hormonal response to sublingual androstenediol intake in young men
Brown, G. A., Martini, E. R., Roberts, B., Vukovich, M. D., & King, D. S. (2002) · Journal of Applied Physiology · doi:10.1152/jappl.2002.92.1.142 · Cited by 47
The effect of nasal drug formulations on ciliary beating in vitro
Romeijn, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04460-2 · Cited by 42
Kaukonen, A. M., Lennernäs, H., & Mannermaa, J. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06894.x · Cited by 40
Srichana, T., Suedee, R., & Reanmongkol, W. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1079 · Cited by 36
Increased bioavailability of clomipramine after sublingual administration in rats
Yoo, S. D., Yoon, B. M., Lee, H. S., & Lee, K. C. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990163p · Cited by 36
Marttin, E., Verhoef, J. C., Romeijn, S. G., Zwart, P., & Merkus, F. W. H. M. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04632-7 · Cited by 35
The influence of absorption enhancers on nasal absorption of acyclovir
Chavanpatil, M. D., & Vavia, P. R. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.01.001 · Cited by 35
Bioavailability of danazol-hydroxypropyl-β-cylodextrin complex by different routes of administration
Badawy, S. I. F., Ghorab, M. M., & Adeyeye, C. M. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04763-1 · Cited by 30
The effects of cyclodextrins on topical delivery of hydrocortisone: the aqueous diffusion layer
Loftsson, Þ., Sigfússon, S. D., Sigurðsson, H. H., & Másson, M. (2003) · Stp Pharma Sciences · Cited by 28
Self-citationCyclodextrin‐Catalyzed Deacetylation of Spironolactone is pH and Cyclodextrin Dependent
Jarho, P., Velde, D. V., & Stella, V. J. (2000) · Journal of Pharmaceutical Sciences · Cited by 27
Self-citationInfluence of Cyclodextrin Complexation on the In Vivo Photoprotective Effects of Oxybenzone
Felton, L. A., Wiley, C. J., & Godwin, D. A. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120027516 · Cited by 24
Blanchard, J., Ugwu, S. O., Bhardwaj, R., & Dorr, R. T. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100100548 · Cited by 20
Wu, W. ‐., Wu, J., & Bodor, N. (2002) · PubMed · Cited by 9
(2000) · CRC Press eBooks · doi:10.1201/9780203483701.ch11 · Cited by 6
Cited by
Review: A History of Cyclodextrins
Crini, G. (2014) · Chemical Reviews · doi:10.1021/cr500081p · Cited by 1,906
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,882
Self-citationCyclodextrins and their pharmaceutical applications
LOFTSSON, T., & DUCHENE, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,764
Self-citationPharmaceutical applications of cyclodextrins: basic science and product development
Loftsson, T., & Brewster, M. E. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01030.x · Cited by 1,031
Self-citationKurkov, S. V., & Loftsson, T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.055 · Cited by 831
Self-citation
Metadata
- Authors
- Loftsson, T., Jarho, P., Másson, M., & Järvinen, T.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2005-03
- Volume
- 2
- Issue
- 2
- Pages
- 335-351
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2107001533
- Cited by
- 793
- References
- 82
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.